6201 - 6250 of 8808 Results
Title
Year
-
OPENTitle: Genetic control of the human brain proteomeJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 108Issue #: 3Start Page: 400End Page: 410Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajhg.2021.01.012Best OA location URL: http://www.cell.com/article/S0002929721000124/pdfCitation Count: 86
-
OPENTitle: Pervasive cis effects of variation in copy number of large tandem repeats on local DNA methylation and gene expressionJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 108Issue #: 5Start Page: 809End Page: 824Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2021.03.016Best OA location URL: http://www.cell.com/article/S0002929721001002/pdfCitation Count: 33
-
OPENTitle: Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imagingJournal Name: Seminars in Arthritis and RheumatismPublisher: Elsevier BVVol: 51Issue #: 5Start Page: 1125End Page: 1133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.semarthrit.2021.08.004Best OA location URL: https://research.vumc.nl/en/publications/d083f460-428b-4cc9-b64c-8e646fc9a1c6Citation Count: 23
-
OPENTitle: Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosisJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 84Issue #:Start Page: 343End Page: 351Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2021.06.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8355084Citation Count: 6
-
OPENTitle: White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 85Issue #:Start Page: 95End Page: 101Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.031Citation Count: 14
-
OPENTitle: A metabolomic study of cervical dystoniaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 98End Page: 103Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7856090Citation Count: 8
-
OPENTitle: How firms undertake organizational changes to shift to more-exploratory strategies: A process perspectiveJournal Name: Research PolicyPublisher: Elsevier BVVol: 50Issue #: 1Start Page: 104118End Page: 104118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104118Best OA location URL: https://minesparis-psl.hal.science/hal-02943926Citation Count: 22
-
RESTRICTEDTitle: Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 128End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.011Citation Count: 0
-
OPENTitle: Predicting Parkinson's disease trajectory using clinical and neuroimaging baseline measuresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 85Issue #:Start Page: 44End Page: 51Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.026Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8127393Citation Count: 18
-
OPENTitle: Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.008Citation Count: 10
-
OPENTitle: Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experienceJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 66End Page: 76Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.018Best OA location URL: http://www.prd-journal.com/article/S1353802021003126/pdfCitation Count: 18
-
OPENTitle: Plasma NfL, clinical subtypes and motor progression in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.016Citation Count: 45
- Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach2021RESTRICTEDTitle: Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approachJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 124End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.011Citation Count: 19
-
RESTRICTEDTitle: Consistent skin α-synuclein positivity in REM sleep behavior disorder – A two center two-to-four-year follow-up studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 108End Page: 113Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.007Best OA location URL: http://hdl.handle.net/11380/1251595Citation Count: 24
-
RESTRICTEDTitle: Visual dysfunction is associated with cognitive impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.005Citation Count: 11
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 5
-
OPENTitle: A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 128End Page: 133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.013Best OA location URL: http://www.prd-journal.com/article/S1353802021002625/pdfCitation Count: 24
-
RESTRICTEDTitle: Telemedicine and Deep brain stimulation - Current practices and recommendationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 199End Page: 205Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.001Citation Count: 25
-
OPENTitle: North American survey on impact of the COVID-19 pandemic shutdown on DBS careJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 41End Page: 45Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.011Best OA location URL: http://www.prd-journal.com/article/S1353802021003667/pdfCitation Count: 8
-
RESTRICTEDTitle: Serum neurofilament light chain predicts future freezing of gait in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 102End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.015Citation Count: 8
-
RESTRICTEDTitle: A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 90End Page: 97Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.034Citation Count: 13
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 12
-
OPENTitle: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scoresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 74End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502Citation Count: 8
-
RESTRICTEDTitle: Increased functional connectivity in a population at risk of developing Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.026Citation Count: 8
-
RESTRICTEDTitle: Coincident parkinsonism and myasthenia gravis: A case seriesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 4End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.016Citation Count: 7
-
OPENTitle: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024Citation Count: 17
-
OPENTitle: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 25End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdfCitation Count: 19
-
OPENTitle: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 79End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdfCitation Count: 66
-
OPENTitle: Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central EuropeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 48End Page: 51Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.026Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8192481Citation Count: 14
-
OPENTitle: Diagnostic criteria for blepharospasm: A multicenter international studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 109End Page: 114Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9048224Citation Count: 30
-
OPENTitle: Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 98End Page: 104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8429254Citation Count: 116
-
OPENTitle: Investigating ELOVL7 coding variants in multiple system atrophyJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 749Issue #:Start Page: 135723End Page: 135723Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2021.135723Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7983070Citation Count: 2
-
RESTRICTEDTitle: The association between multiple risk factors, clinical correlations and molecular insights in Parkinson’s disease patients from Tamil Nadu population, IndiaJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 755Issue #:Start Page: 135903End Page: 135903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2021.135903Citation Count: 22
-
OPENTitle: ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802021003539/pdfCitation Count: 42
-
OPENTitle: Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 59End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.009Best OA location URL: http://www.prd-journal.com/article/S1353802021003643/pdfCitation Count: 49
-
OPENTitle: Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cellsJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 147Issue #:Start Page: 105070End Page: 105070Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuint.2021.105070Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7610942Citation Count: 23
-
RESTRICTEDTitle: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 186Issue #:Start Page: 108465End Page: 108465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465Citation Count: 17
-
RESTRICTEDTitle: Quantitative Cellular Changes in the Thalamus of Patients with Multiple System AtrophyJournal Name: NeurosciencePublisher: Elsevier BVVol: 459Issue #:Start Page: 142End Page: 152Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.003Citation Count: 4
-
RESTRICTEDTitle: Motor Thalamic Deep Brain Stimulation Alters Cortical Activity and Shows Therapeutic Utility for Treatment of Parkinson’s Disease Symptoms in a Rat ModelJournal Name: NeurosciencePublisher: Elsevier BVVol: 460Issue #:Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.019Citation Count: 6
-
OPENTitle: Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 157Issue #:Start Page: 105426End Page: 105426Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105426Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105426Citation Count: 12
- Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma2020OPENTitle: Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head traumaJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 150Issue #:Start Page: 105237End Page: 105237Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105237Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996120305131?via%3DihubCitation Count: 20
-
RESTRICTEDTitle: Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnosesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 105Issue #:Start Page: 378.e1End Page: 378.e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.04.011Citation Count: 14
-
RESTRICTEDTitle: Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 97Issue #:Start Page: 120End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.016Citation Count: 13
-
RESTRICTEDTitle: Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 97Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.06.007Citation Count: 57
-
OPENTitle: Altered network stability in progressive supranuclear palsyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 107Issue #:Start Page: 109End Page: 117Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.07.007Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.07.007Citation Count: 13
- Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's disease2020OPENTitle: Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 226Issue #:Start Page: 117568End Page: 117568Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroimage.2020.117568Best OA location URL: https://doi.org/10.1016/j.neuroimage.2020.117568Citation Count: 21
-
OPENTitle: Connectivity correlates to predict essential tremor deep brain stimulation outcome: Evidence for a common treatment pathwayJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 32Issue #:Start Page: 102846End Page: 102846Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2021.102846Best OA location URL: https://doi.org/10.1016/j.nicl.2021.102846Citation Count: 43
-
OPENTitle: Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagyJournal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 24Start Page: 5082End Page: 5098.e11Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.molcel.2021.10.001Best OA location URL: http://www.cell.com/article/S1097276521008005/pdfCitation Count: 83
-
OPENTitle: The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44Journal Name: Molecular Genetics and MetabolismPublisher: Elsevier BVVol: 133Issue #: 1Start Page: 109End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ymgme.2021.03.012Citation Count: 3
-
OPENTitle: Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 2821End Page: 2840Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymthe.2021.04.035Best OA location URL: https://eprints.ncl.ac.uk/275504Citation Count: 38